Generic Name and Formulations:
Anthralin 1%; crm, contains salicylic and ascorbic acid.
Indications for DRITHO-CREME:
Quiescent or chronic psoriasis.
Initially apply once daily (5–10 minutes contact time) for at least one week; may increase contact time to 20–30 minutes before washing off. Treat until skin is entirely clear. Individualize. For skin: use sparingly. For scalp: wash and rinse hair.
Acute psoriatic eruptions.
Renal disease. Avoid eyes, mucous membranes, folds and creases of the skin. Apply cautiously on intertriginous skin areas. Restrict application to psoriatic lesions. Discontinue if sensitization or excessive irritation develops. May stain fabrics; avoid. Pregnancy (Cat.C). Nursing mothers.
Possible contact allergic reactions, severe irritation, discolored hair or fingernails.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Triiodothyronine in the Treatment of Bipolar Depression
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Personal Health Information Found in Recycling
- Nightmares in Military Personnel Frequently Comorbid With Mental Health Disorders
- Potential for SERMs as Adjunctive Therapy for Schizophrenia
- Addressing Racial Disparities in Bipolar Disorder Treatment
- Negative Symptoms Increase Cardiovascular Risk in Schizophrenia